CryptoWorld News: The U.S. Food and Drug Administration (FDA) is leveraging artificial intelligence technology to accelerate the clinical trial process. This initiative aims to improve the efficiency and accuracy of clinical trials, promoting the development and approval of new drugs.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments